R&D Partner Content 4th Ligase Targeting Drug Development Summit 2024 Successfully Progressing Towards Efficacious Degrader Drugs with Novel Ligases & Ligands
R&D Partner Content 3rd Cell Therapy Potency Assay Summit The 3rd Cell Therapy Potency Assay Summit will bring together 100+ analytical, QC and regulatory experts to discuss the new FDA guidance and address all pressing concerns that are limiting
R&D Partner Content 5th Supply Chain & Logistics for Cell Therapies Summit Uniting Supply Chain & Clinical Operation Leaders
R&D Partner Content 5th TCR-based Therapies for Solid Tumors Summit Advancing TCR-based Cell Therapies & Bispecific Approaches
R&D Partner Content Biophysics for Drug Discovery Summit Advance Biophysics Technologies & Applications to Measure Molecular & Target Interactions
R&D Partner Content Polymer Chemistry & Formulation in Drug Delivery Design Your Novel Polymers & Maximize Payload Compatibility for Sustained & Controlled Release
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
